ECM
TNDM icon

Evergreen Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Evergreen Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,992
Closed -$249K – 1664
2026
Q1 		$249K Buy
+12,992
New +$282K 0.01% 1251
2025
Q1 		– Sell
-5,945
Closed -$214K – 1177
2024
Q4 		$214K Sell
5,945
-727
-11% -$24.6K 0.01% 948
2024
Q3 		$283K Sell
6,672
-264
-4% -$11.2K 0.01% 742
2024
Q2 		$279K Buy
6,936
+758
+12% +$31.6K 0.01% 688
2024
Q1 		$219K Buy
+6,178
New +$166K 0.01% 762

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Evergreen Capital Management's TNDM Position: Q2 2026 in Review

Evergreen Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 12,992 shares — an estimated $249K sold.

Evergreen Capital Management first reported a position in TNDM in Q1 2024 and held it in 5 quarters. The position peaked at $283K in Q3 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Evergreen Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • Evergreen Capital Management sold 12,992 Tandem Diabetes Care shares in Q2 2026, an estimated $249K.
  • Evergreen Capital Management first reported a position in Tandem Diabetes Care in Q1 2024 and held it in 5 quarters.
  • Evergreen Capital Management's Tandem Diabetes Care position peaked at $283K in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.